摘要
帕金森病是一种多发于中老年人的神经系统变性疾病,至今尚无有效的治愈方法。若能早期确诊,及时进行神经保护治疗,则对抑制帕金森病的进一步发展具有重要意义。目前,核医学技术已被广泛应用于该病的早期诊断和鉴别诊断研究。本文对核医学技术诊断帕金森病的研究进展作一综述。
出处
《国际神经病学神经外科学杂志》
2007年第1期83-86,共4页
Journal of International Neurology and Neurosurgery
基金
国家自然科学青年基金(30400516)
武汉青年科技晨光计划(20045006071-2)
参考文献25
-
1Bjarkam CR,Sorensen JC.Therapeutic strategies for neurodegenerative disorders:emerging clues from Parkinson's disease.Biol Psychiatry,2004,56(4):213-216.
-
2Bemheimer H,Birkmayer W,Hornykiewicz O,et al.Brain dopamine and the syndromes of Parkinson and Huntington.Clinical,morphological and neurochemical correlations.J Neurol Sci,1973,20(4):41 5-455.
-
3Snow BJ,Tooyama I,McGeer EG,et al.Human positron emission tomographic[^18 F]fluorodopa studies correlate with dopamine cell counts and levels.Ann Neurol,1993,34(3):324-330.
-
4Brooks DJ.Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease.J Neurol,2000,247(S2):Ⅱ11-18.
-
5Otsuka M,Ichiya Y,Kuwabara Y,et al.Differences in the reduced ^18 F-Dopa uptakes of the eaudate and the putamen in Parkinson's disease:correlations with the three main symptoms.J Neurol Sci,1996,136(1-2):169-173.
-
6Piccini P,Morrish PK,Turjanski N,et al.Dopaminergic function in familial Parkinson's disease:a clinical and ^18F-dopa PET study.Ann Neurol,1997,41(2):222-229.
-
7Bruck A,Aaho S,Nurmi E,et al.Cortical 6-[^18 F]fluorol-dopa uptake and frontal cognitive functions in early Parkinson's disease.Neurobiol Aging,2005,26(6):891-898.
-
8Whone ALRP,Davis MR,Sabolek M,et al.Slower progression in early Parkinson's disease treated with ropinirole compared with L-dopa:The REAL-PET study.Ann Neurol,2003,54(1):93-101.
-
9Ghaemi M,Hilker R,Rudolf J,et al.Differentiating multiple system atrophy from Parkinson's disease:contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging.J Neurol Neurosurg Paychiatry,2002,73(5):517-523.
-
10Hilker R,Razai N,Ghaemi M,et al.[^18 F]Fluorodopa uptake in the upper brainstem measured with positron emission tomography correlates with decreased REM sleep duration in early Parkinson's disease.Clin Neurol Neurosurg,2003,105(4):262-269.
同被引文献26
-
1张锦明,田嘉禾,郭喆,丁为民,姚树林,尹大一,刘伯里.在线自动化制备多巴胺转运蛋白显像剂^(11)C-β-CFT[J].中华核医学杂志,2005,25(3):142-145. 被引量：25
-
2陈生第.帕金森病临床新技术.北京:人民军医出版社,2002:41-104.
-
3Ishikawa A, Takahashi H. Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism. J Neurol, 1998, 245 (11 suppl 3): P4-P9.
-
4Cham R, Studenski SA, Perera S, et al. Striatal dopaminergic denervation and gait in healthy adults. Exp Brain Res, 2008, 185 (3): 391-398.
-
5Rinne JO, Ruottinen H, Bergman J, et al. Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease. J Neurol Neurosurg Psychiatry, 1999, 67(6): 737-741.
-
6Haaparanta M, Bergman J, Laakso A, et al. [^18F]CFT ([^18F]WIN 35, 428), a radioligand to study the dopamine transporter with PET; biodistribution in rats. Synapse, 1996, 23(4): 321-327.
-
7Chitneni SK, Garreau L, Cleynhens B, et al. Improved synthesis and metabolic stability analysis of the dopamine transporter ligand [^18F]FECT. Nucl Med Biol, 2008, 35(1): 75-82.
-
8Emond P, Guilloteau D, Chalon S. PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter. CNS Neurosci Ther, 2008, 14(1): 47-64.
-
9Ouchi Y, Kanno T, Okada H, et al. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease. Brain, 2001, 124 (pt 4): 784-792.
-
10Rinne JO, Laine M, Kaasinen V, et al. Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia. Neurology, 2002, 58(10): 1489-1493.
引证文献2
-
1柴黎明,杨小丰,王爽,吴君,赵周社.多巴胺转运体显像剂^11C—CFT和^18F-CFT及其临床应用进展[J].国际放射医学核医学杂志,2009,33(4):232-234. 被引量：2
-
2徐子入,毛明宇,张宇,朱金诺,熊青青,黄宁静.止颤汤对肝肾不足型帕金森病患者肠道菌群影响的随机对照研究[J].世界临床药物,2022,43(10):1307-1313. 被引量：2
二级引证文献4
-
1邱春,左传涛,张政伟,吴平,张慧玮,管一晖.不同显像时间窗对^11C—CFT PET／CT显像测多巴胺转运蛋白分布半定量值的影响[J].中华核医学与分子影像杂志,2013,33(5):362-366. 被引量：8
-
2李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂^11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218-224. 被引量：2
-
3汪俊.止颤汤联合多巴丝肼片对肝肾阴虚型帕金森病患者的影响[J].医学理论与实践,2024,37(2):216-218.
-
4马龙.加味镇肝熄风汤辅治帕金森病临床观察[J].实用中医药杂志,2024,40(1):97-99.
-
1庞善军,彭玉华.血管性认知功能损害的磁共振成像研究进展[J].医学影像学杂志,2010,20(5):750-752.
-
2抑郁症能治好吗?[J].家庭科技,2006(6):39-39.
-
3曹腽,靳令经.干细胞移植治疗帕金森病的细胞类型及其选择[J].上海医学,2015,38(1):79-82.
-
4李梦,方立,滕军放.帕金森病的早期检测技术研究进展[J].河南医学研究,2014,23(3):151-153. 被引量：4
-
5顾加和,李澄,王礼同.动脉自旋标记技术研究进展及其在短暂性脑缺血发作中的应用[J].中国医学影像技术,2016,32(3):465-469. 被引量：12
-
6钟洁,刘泰.我国脑卒中社区康复技术研究进展[J].中西医结合心脑血管病杂志,2010,8(11):1371-1373. 被引量：1
-
7汪凯,周珊珊.神经心理学在神经病学中的重要作用[J].中国现代神经疾病杂志,2007,7(6):481-484.
-
8叶玉琴,王可人,朱丹,刘晶瑶,江新梅.吉兰-巴雷综合征的治疗进展[J].中风与神经疾病杂志,2011,28(8):762-763.
-
9孙伟伟,牛成玲,王凤羽.假肥大型肌营养不良基因诊断技术研究进展[J].国际遗传学杂志,2011,34(4):196-201. 被引量：1
-
10邓大丽,余锋,喻廉,刘会林,徐莉.癫痫灶定位技术研究进展[J].安徽医学,2011,32(10):1790-1792. 被引量：10
